Premium
ISBT 128 implementation plan for cellular therapy products
Author(s) -
Ashford Paul,
Distler Pat,
Gee Adrian,
Lankester Alan,
Larsson Stella,
Feller Irene,
Loper Kathy,
Pamphilon Derwood,
Poston Leigh,
Rabe Fran,
SlaperCortenbach Ineke,
Szczepiorkowski Zbigniew,
Warkentin Phyllis
Publication year - 2007
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.20146
Subject(s) - medicine , traceability , terminology , consistency (knowledge bases) , plan (archaeology) , risk analysis (engineering) , process management , engineering management , management science , software engineering , computer science , engineering , artificial intelligence , linguistics , philosophy , archaeology , history
The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the global level. However, it is only with the widespread implementation of the standard that the benefits can be truly realized. This paper provides guidance on the practical aspects of adopting these new standards for organizations with differing current levels of computerization. It discusses project management, equipment, licensing, and validation topics. J. Clin. Apheresis, 2007. © 2007 Internal Cellular Therapy Coding and Labeling Advisory Group.